KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Interest & Investment Income (2019 - 2025)

Biolife Solutions (BLFS) has disclosed Interest & Investment Income for 9 consecutive years, with $833000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 2676.67% to $833000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 million, a 506.92% increase, with the full-year FY2025 number at $2.7 million, up 453.26% from a year prior.
  • Interest & Investment Income was $833000.0 for Q4 2025 at Biolife Solutions, up from $508000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $833000.0 in Q4 2025 to a low of -$476000.0 in Q3 2023.
  • A 5-year average of -$9600.0 and a median of -$130500.0 in 2021 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: plummeted 3073.33% in 2023, then surged 2676.67% in 2025.
  • Biolife Solutions' Interest & Investment Income stood at -$154000.0 in 2021, then skyrocketed by 51.95% to -$74000.0 in 2022, then plummeted by 156.76% to -$190000.0 in 2023, then skyrocketed by 115.79% to $30000.0 in 2024, then soared by 2676.67% to $833000.0 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Interest & Investment Income are $833000.0 (Q4 2025), $508000.0 (Q3 2025), and $684000.0 (Q2 2025).